Literature DB >> 18650376

The contrasting role of B7-H3.

Kimberly A Hofmeyer1, Anjana Ray, Xingxing Zang.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18650376      PMCID： PMC2492485          DOI： 10.1073/pnas.0805458105

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  20 in total

1.  Identification of 4Ig-B7-H3 as a neuroblastoma-associated molecule that exerts a protective role from an NK cell-mediated lysis.

Authors:  Roberta Castriconi; Alessandra Dondero; Raffaella Augugliaro; Claudia Cantoni; Barbara Carnemolla; Angela Rita Sementa; Francesca Negri; Romana Conte; Maria Valeria Corrias; Lorenzo Moretta; Alessandro Moretta; Cristina Bottino
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-16       Impact factor: 11.205

2.  The immune regulatory protein B7-H3 promotes osteoblast differentiation and bone mineralization.

Authors:  W-K Suh; S X Wang; A H Jheon; L Moreno; S K Yoshinaga; B Ganss; J Sodek; M D Grynpas; T W Mak
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-18       Impact factor: 11.205

Review 3.  The TREM receptor family and signal integration.

Authors:  Julia Klesney-Tait; Isaiah R Turnbull; Marco Colonna
Journal:  Nat Immunol       Date:  2006-12       Impact factor: 25.606

4.  Arsenic trioxide synergizes with B7H3-mediated immunotherapy to eradicate hepatocellular carcinomas.

Authors:  Liqiong Luo; Haiquan Qiao; Fanqiang Meng; Xuesong Dong; Baoguo Zhou; Hongchi Jiang; Jagat R Kanwar; Geoffrey W Krissansen; Xueying Sun
Journal:  Int J Cancer       Date:  2006-04-01       Impact factor: 7.396

5.  B7-H3: a costimulatory molecule for T cell activation and IFN-gamma production.

Authors:  A I Chapoval; J Ni; J S Lau; R A Wilcox; D B Flies; D Liu; H Dong; G L Sica; G Zhu; K Tamada; L Chen
Journal:  Nat Immunol       Date:  2001-03       Impact factor: 25.606

6.  B7-H3 promotes acute and chronic allograft rejection.

Authors:  Liqing Wang; Christopher C Fraser; Kristine Kikly; Andrew D Wells; Rongxiang Han; Anthony J Coyle; Lieping Chen; Wayne W Hancock
Journal:  Eur J Immunol       Date:  2005-02       Impact factor: 5.532

7.  An orthotopic colon cancer model for studying the B7-H3 antitumor effect in vivo.

Authors:  Catalin M Lupu; Christoph Eisenbach; Michael A Kuefner; Jan Schmidt; Alaviana D Lupu; Wolfgang Stremmel; Jens Encke
Journal:  J Gastrointest Surg       Date:  2006-05       Impact factor: 3.452

8.  Trem-like transcript 2 is expressed on cells of the myeloid/granuloid and B lymphoid lineage and is up-regulated in response to inflammation.

Authors:  R Glenn King; Brantley R Herrin; Louis B Justement
Journal:  J Immunol       Date:  2006-05-15       Impact factor: 5.422

9.  B7-H3 enhances tumor immunity in vivo by costimulating rapid clonal expansion of antigen-specific CD8+ cytolytic T cells.

Authors:  Liqun Luo; Andrei I Chapoval; Dallas B Flies; Gefeng Zhu; Fumiya Hirano; Shengdian Wang; Julie S Lau; Haidong Dong; Koji Tamada; Andrew S Flies; Yang Liu; Lieping Chen
Journal:  J Immunol       Date:  2004-11-01       Impact factor: 5.422

10.  Murine B7-H3 is a negative regulator of T cells.

Authors:  Durbaka V R Prasad; Thang Nguyen; Zhaoxia Li; Yang Yang; Julie Duong; Ying Wang; Chen Dong
Journal:  J Immunol       Date:  2004-08-15       Impact factor: 5.422
View more
  74 in total

Review 1.  T cell coinhibition in prostate cancer: new immune evasion pathways and emerging therapeutics.

Authors:  Yael S Barach; Jun Sik Lee; Xingxing Zang
Journal:  Trends Mol Med       Date:  2011-01       Impact factor: 11.951

2.  B7-H3 Expression in Merkel Cell Carcinoma-Associated Endothelial Cells Correlates with Locally Aggressive Primary Tumor Features and Increased Vascular Density.

Authors:  Phyu P Aung; Edwin Roger Parra; Souptik Barua; Dawen Sui; Jing Ning; Barbara Mino; Debora Alejandra Ledesma; Jonathan L Curry; Priyadharsini Nagarajan; Carlos A Torres-Cabala; Eleni Efstathiou; Anh G Hoang; Michael K Wong; Jennifer A Wargo; Alexander J Lazar; Arvind Rao; Victor G Prieto; Ignacio Wistuba; Michael T Tetzlaff
Journal:  Clin Cancer Res       Date:  2019-02-26       Impact factor: 12.531

3.  Cellular-Based Selections Aid Yeast-Display Discovery of Genuine Cell-Binding Ligands: Targeting Oncology Vascular Biomarker CD276.

Authors:  Lawrence A Stern; Patrick S Lown; Alexandra C Kobe; Lotfi Abou-Elkacem; Juergen K Willmann; Benjamin J Hackel
Journal:  ACS Comb Sci       Date:  2019-01-24       Impact factor: 3.784

Review 4.  Emerging immunotherapies for bladder cancer.

Authors:  Joseph W Kim; Yusuke Tomita; Jane Trepel; Andrea B Apolo
Journal:  Curr Opin Oncol       Date:  2015-05       Impact factor: 3.645

5.  Humanized Affinity-matured Monoclonal Antibody 8H9 Has Potent Antitumor Activity and Binds to FG Loop of Tumor Antigen B7-H3.

Authors:  Mahiuddin Ahmed; Ming Cheng; Qi Zhao; Yehuda Goldgur; Sarah M Cheal; Hong-fen Guo; Steven M Larson; Nai-kong V Cheung
Journal:  J Biol Chem       Date:  2015-10-20       Impact factor: 5.157

6.  Overexpression of B7-H3 augments anti-apoptosis of colorectal cancer cells by Jak2-STAT3.

Authors:  Ting Zhang; Bo Jiang; Shi-Tao Zou; Fen Liu; Dong Hua
Journal:  World J Gastroenterol       Date:  2015-02-14       Impact factor: 5.742

7.  High expression of B7-H3 and CD163 in cancer tissues indicates malignant clinicopathological status and poor prognosis of patients with urothelial cell carcinoma of the bladder.

Authors:  Zhili Xu; Ling Wang; Jianhua Tian; Hongwei Man; Pengfei Li; Baoen Shan
Journal:  Oncol Lett       Date:  2018-03-05       Impact factor: 2.967

8.  Novel diagnostic biomarkers for prostate cancer.

Authors:  Chikezie O Madu; Yi Lu
Journal:  J Cancer       Date:  2010-10-06       Impact factor: 4.207

9.  HHLA2 is a member of the B7 family and inhibits human CD4 and CD8 T-cell function.

Authors:  Ruihua Zhao; Jordan M Chinai; Susan Buhl; Lisa Scandiuzzi; Anjana Ray; Hyungjun Jeon; Kim C Ohaegbulam; Kaya Ghosh; Aimin Zhao; Matthew D Scharff; Xingxing Zang
Journal:  Proc Natl Acad Sci U S A       Date:  2013-05-28       Impact factor: 11.205

10.  Wide Expression and Significance of Alternative Immune Checkpoint Molecules, B7x and HHLA2, in PD-L1-Negative Human Lung Cancers.

Authors:  Haiying Cheng; Alain Borczuk; Murali Janakiram; Xiaoxin Ren; Juan Lin; Amer Assal; Balazs Halmos; Roman Perez-Soler; Xingxing Zang
Journal:  Clin Cancer Res       Date:  2018-01-26       Impact factor: 12.531
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.